Evidence map›Paper›PMID 37405263›Full record

ArticleChina CDC weekly2023

Utilization of Smoking Cessation Support Among Adults - 18 PLADs, China, 2020.

Yongfu Yan, Bingliang Lin, Qingqing Xu, Huiyu Xie, Xinying Zeng, Xinbo Di, Zida Meng, Lin Xiao, Shiwei Liu

Abstract read
In one paragraph

Article in China CDC weekly, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Integrating tobacco control into China's health management: Strategies for healthier China.Chinese medical journal pulmonary and critical care medicine · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yongfu YanTobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China.
Bingliang LinTobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China.
Qingqing XuTobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China.
Huiyu XieTobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China.
Xinying ZengTobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China.
Xinbo DiTobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China.
Zida MengTobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China.
Lin XiaoTobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China.
Shiwei LiuTobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: In 2018, unassisted smoking cessation (USC) was the predominant method for quitting smoking among Chinese adult smokers, accounting for 90.1% of cases. The utilization of professional smoking cessation support was comparatively low in this population. What is added by this report?: In 2020, the prevalence of USC methods increased to 93.1%. Concurrently, there was a slight increase in the utilization of pharmaceuticals (from 4.6% in 2018 to 5.5% in 2020) and counseling and quit line services (from 3.2% in 2018 to 7.5% in 2020). On the other hand, the use of e-cigarettes as a cessation aid decreased from 14.9% in 2018 to 9.8% in 2020. Smokers aged 15-24 years old were more likely to rely on pharmaceutical interventions (7.9%), and less likely to choose USC methods (79.0%). What are the implications for public health practice?: The promotion of professional cessation support is essential for enhancing smoking cessation rates.

Indexed as

AdultsChinaSmoking cessation support

Identifiers

PMID37405263
PMCPMC10316591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.